Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC
Fen Wang ... Qing Zhou
Journal of Thoracic Oncology | VOL. 17
Fen Wang, et. al.Fen Wang ... Qing Zhou
17 Mar 2022
Chemotherapy and Survival in Non-Small Cell Lung Cancer: The Old Vexata Questio
Gianfranco Buccheri
Chest | VOL. 99
Gianfranco BuccheriGianfranco Buccheri
01 Jun 1991
Second-Line Chemotherapy for Non-small Cell Lung Cancer
John C Ruckdeschel
Chest | VOL. 129
John C RuckdeschelJohn C Ruckdeschel
01 Apr 2006
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Letetresgene Autoleucel in Advanced/Metastatic Myxoid/Round Cell Liposarcoma
Sandra P D'Angelo ... Neeta Somaiah
Journal of Clinical Oncology | VOL. -
Sandra P D'Angelo, et. al.Sandra P D'Angelo ... Neeta Somaiah
21 Jan 2025
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
Jordi Remon ... Benjamin Besse
Journal of Clinical Oncology | VOL. -
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
21 Jan 2025
Reply to: Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?
Skander Jemaa ... Richard A.D Carano
Journal of Clinical Oncology | VOL. -
Skander Jemaa, et. al.Skander Jemaa ... Richard A.D Carano
21 Jan 2025
Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?
Vít Procházka ... Jaroslav Ptáček
Journal of Clinical Oncology | VOL. -
Vít Procházka, et. al.Vít Procházka ... Jaroslav Ptáček
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.